References
- Chu X, Bleasby K, Evers R. (2013). Species differences in drug transporters and implications for translating preclinical findings to humans. Expert Opin Drug Metab Toxicol 9:237–52
- Cui Y, König J, Leier I, et al. (2001). Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem 276:9626–30
- Gardiner P, Paine SW. (2011). The impact of hepatic uptake on the pharmacokinetics of organic anions. Drug Metab Dispos 39:1930–8
- Grime K, Paine SW. (2013). Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement. Drug Metab Dispos 41:372–8
- Hagenbuch B, Meier PJ. (2003). The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta 1609:1–18
- Hisaka A, Sugiyama Y. (1998). Analysis of nonlinear and nonsteady state hepatic extraction with the dispersion model using the finite difference method. J Pharmacokinet Biopharm 26:495–519
- Kosaka K, Sakai N, Endo Y, et al. (2011). Impact of intestinal glucuronidation on the pharmacokinetics of raloxifene. Drug Metab Dispos 39:1495–502
- Kuroda M, Kobayashi Y, Tanaka Y, et al. (2004). Increased hepatic and renal expressions of multidrug resistance-associated protein 3 in Eisai hyperbilirubinuria rats. J Gastroenterol Hepatol 19:146–53
- Li M, Yuan H, Li N, et al. (2008). Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human. Eur J Pharm Sci 35:114–26
- Li N, Zhang Y, Hua F, Lai Y. (2009). Absolute difference of hepatobiliary transporter multidrug resistance-associated protein (MRP2/Mrp2) in liver tissues and isolated hepatocytes from rat, dog, monkey, and human. Drug Metab Dispos 37:66–73
- Morikawa A, Goto Y, Suzuki H, et al. (2000). Biliary excretion of 17beta-estradiol 17beta-D-glucuronide is predominantly mediated by cMOAT/MRP2. Pharm Res 17:546–52
- Ninomiya M, Ito K, Horie T. (2005). Functional analysis of dog multidrug resistance-associated protein 2 (Mrp2) in comparison with rat Mrp2. Drug Metab Dispos 33:225–32
- Ohtsuki S, Schaefer O, Kawakami H, et al. (2012). Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities. Drug Metab Dispos 40:83–92
- Reichel C, Gao B, Van Montfoort J, et al. (1999). Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver. Gastroenterology 117:688–95
- Sathirakul K, Suzuki H, Yasuda K, et al. (1993). Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats. J Pharmacol Exp Ther 265:1301–12
- Soars MG, Grime K, Sproston JL, et al. (2007). Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo. Drug Metab Dispos 35:859–65
- Yamashiro W, Maeda K, Hirouchi M, et al. (2006). Involvement of transporters in the hepatic uptake and biliary excretion of Valsartan, a selective antagonist of angiotensin II AT1-receptor, in humans. Drug Metab Dispos 34:1247–54